PRospective Evaluation Complementing Investigation With Acurate Neo Device

NCT03846557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-06-18

No results posted yet for this study

Summary

The study collects real-world data of patients who were treated with the Acurate Neo TAVI System and evaluates early and midterm clinical outcomes.

Conditions

  • Aortic Stenosis

Interventions

DEVICE

Transcatheter Aortic Valve Implantation (TAVI)

Implantation of the Acurate Neo Transcatheter Heart Valve

Sponsors & Collaborators

  • Fundación EPIC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-20
Primary Completion
2021-09-02
Completion
2021-10-02

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03846557 on ClinicalTrials.gov